Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David N Church

Showing results (1-10 of 63) with videos related to

Pageof 7
Sort By:
Cancer Treatment Reviews|September 30, 2006
Clinical review - small cell carcinoma of the bladderDavid N Church, Amit Bahl
Current Oncology Reports|August 31, 2012
In reply: response to MarioniDavid N Church, Denis C Talbot
Current Oncology Reports|January 12, 2012
Survivin in solid tumors: rationale for development of inhibitorsDavid N Church, Denis C Talbot
Chinese Clinical Oncology|April 6, 2015
Stage II colon cancerDavid N Church, Rachel Midgley, David J Kerr
JAMA Oncology|January 16, 2016
Neoepitopes and CD3-Positive and CD8-Positive Cells in Polymerase e-Mutated and Microsatellite-Instable Endometrial CancersInge C van Gool, Tjalling Bosse, David N Church
Oncoimmunology|May 4, 2016
<i>POLE</i> proofreading mutation, immune response and prognosis in endometrial cancerInge C van Gool, Tjalling Bosse, David N Church
The Journal of Pathology|November 19, 2016
Cancer predisposition syndromes: lessons for truly precision medicineMark A Glaire, Matthew Brown, David N Church, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|November 28, 2015
Vaccination of chemotherapy patients--effect of guideline implementationMichelle S Toleman, Katharine Herbert, Noel McCarthy, et al.
Nature Reviews. Cancer|January 30, 2016
A panoply of errors: polymerase proofreading domain mutations in cancerEmily Rayner, Inge C van Gool, Claire Palles, et al.
Ebiomedicine|September 3, 2021
Automated assessment of CD8<sup>+</sup> T-lymphocytes and stroma fractions complement conventional staging of colorectal cancerDan Jiang, Tarjei S Hveem, Mark Glaire, et al.
Pageof 7

Showing results (1-10 of 63) with videos related to

Sort By:
Pageof 7
Cancer Treatment Reviews|September 30, 2006
Clinical review - small cell carcinoma of the bladderDavid N Church, Amit Bahl
Current Oncology Reports|August 31, 2012
In reply: response to MarioniDavid N Church, Denis C Talbot
Current Oncology Reports|January 12, 2012
Survivin in solid tumors: rationale for development of inhibitorsDavid N Church, Denis C Talbot
Chinese Clinical Oncology|April 6, 2015
Stage II colon cancerDavid N Church, Rachel Midgley, David J Kerr
JAMA Oncology|January 16, 2016
Neoepitopes and CD3-Positive and CD8-Positive Cells in Polymerase e-Mutated and Microsatellite-Instable Endometrial CancersInge C van Gool, Tjalling Bosse, David N Church
Oncoimmunology|May 4, 2016
<i>POLE</i> proofreading mutation, immune response and prognosis in endometrial cancerInge C van Gool, Tjalling Bosse, David N Church
The Journal of Pathology|November 19, 2016
Cancer predisposition syndromes: lessons for truly precision medicineMark A Glaire, Matthew Brown, David N Church, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|November 28, 2015
Vaccination of chemotherapy patients--effect of guideline implementationMichelle S Toleman, Katharine Herbert, Noel McCarthy, et al.
Nature Reviews. Cancer|January 30, 2016
A panoply of errors: polymerase proofreading domain mutations in cancerEmily Rayner, Inge C van Gool, Claire Palles, et al.
Ebiomedicine|September 3, 2021
Automated assessment of CD8<sup>+</sup> T-lymphocytes and stroma fractions complement conventional staging of colorectal cancerDan Jiang, Tarjei S Hveem, Mark Glaire, et al.
Pageof 7